Unfortunately, the knockdown of CBX8 did not affect the expression of p16ink4a-arf in HCT116 and HT29 cells (data not shown), indicating that CBX8 inhibits the growth of CRC cells independent of p16ink4a-arf. The gene discussed is CDKN2A; the disease is colorectal carcinoma.